Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.39 |
| ▸ | PPM1B | O75688 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | AGL | P35573 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8427865 | 1.00 | SPHK1 (0.39) | SPHK1PPM1BPTPN1PPP1CCMAPT | |
| SCHEMBL19973666 | 1.00 | SPHK1 (0.39) | SPHK1PPM1BPTPN1PPP1CCMAPT | |
| SCHEMBL3388749 | 1.00 | SPHK1 (0.39) | SPHK1PPM1BPTPN1PPP1CCMAPT | |
| SCHEMBL116264 | 1.00 | SPHK1 (0.39) | SPHK1PPM1BPTPN1PPP1CCMAPT | |
| Hydrochloric Acid SCHEMBL4489520 | 0.98 | SPHK1 (0.38) | SPHK1PPM1BPTPN1PPP1CCMAPT | |
| Hydrochloric Acid SCHEMBL953016 | 0.98 | SPHK1 (0.38) | SPHK1PPM1BPTPN1PPP1CCMAPT | |
| Hydrochloric Acid SCHEMBL5578417 | 0.98 | SPHK1 (0.38) | SPHK1PPM1BPTPN1PPP1CCMAPT | |
| SCHEMBL15955679 | 0.83 | SPHK1 (0.44) | SPHK1TSHR | |
| SCHEMBL23555977 | 0.82 | ALDH1A1 (0.40) | PPM1BPTPN1PPP1CCMAPT | |
| SCHEMBL24524725 | 0.82 | ALDH1A1 (0.40) | PPM1BPTPN1PPP1CCMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6770741-B1 | USEFUL IN TREATING CONDITIONS AND DISEASES OF A MAMMAL AND HUMAN IN WHICH AN EXCESS OF BRADYKININ OR RELATED KININS ARE PRODUCED OR INJECTED SUCH AS BY INSECT BITES | SCIOS INC. | 2004-08-03 | — | — | US | disclosed |
| EP-0618810-B1 | BRADYKININ ANTAGONIST PEPTIDES | SCIOS NOVA INC (US) | 2001-07-04 | — | — | EP | disclosed |
| US-5385889-A | Substitution of L-proline at the 7-position of the peptide hormone with a D-configuration hydroxyproline ether or thioether converts agonist into antagonist | SCIOS NOVA INC. (US) | 1995-01-31 | — | — | US | disclosed |
| EP-0618810-A4 | BRADYKININ ANTAGONIST PEPTIDES. | SCIOS NOVA INC (US) | 1994-12-07 | — | — | EP | disclosed |
| EP-0618810-A1 | BRADYKININ ANTAGONIST PEPTIDES | SCIOS NOVA INC. (US) | 1994-10-12 | — | — | EP | disclosed |
| WO-1992018156-A1 | BRADYKININ ANTAGONIST PEPTIDES | NOVA TECHNOLOGY LIMITED PARTNERSHIP (US) | 1992-10-29 | — | — | WO | disclosed |